Skip to main content

TABLE 1.

IgM and IgG reactivity to NRA and SMB antigen in a panel of coded human serum specimensa

Specimen no. (day postonset) ELISA titer
Nt antibody titer
IgM
IgG
NRA SMB
NRA SMB
NY99 virus Eg-101 virus SLE virus NY99 virus Eg-101 virus SLE virus
Positive control 4.19 4.46 5.16 4.54 5.00 4.82 ND
1 (20) 7.42 7.15 6.59 3.74 7.22 6.30 5.12 7.93 1:1,280
2 (14) 4.26 3.12 4.34 1.14 1.14 1.31 1.40 1.8 ND
3 (16) 6.00 5.39 6.18 2.08 1.61 1.85 1.95 2.53 <1:10
4 (30) 3.04 2.23 2.47 1.21 8.48 7.83 6.34 ND 1:160
5 (68) 5.01 5.85 6.28 1.44 1.10 1.14 1.19 1.02 ND
6 (?) 7.30 4.11 3.51 1.11 8.57 8.84 7.76 11.54 1:320
7 (43) 1.90 1.76 2.69 0.79 7.82 7.66 6.40 3.61 ND
8 (20) 1.12 0.98 0.95 0.91 1.53 1.64 1.70 ND ND
9 (3) 1.53 1.37 2.17 1.13 6.88 7.12 6.07 ND 1:5120
10 (3) 6.43 4.69 6.04 1.87 3.94 4.23 4.38 2.31 <1:10
11 (7) 6.71 4.59 5.78 1.86 3.74 4.30 3.48 2.74 1:20
12 (10) 1.14 1.06 1.17 0.96 6.30 6.59 5.11 7.28 ND
13 (?) 1.13 0.90 1.13 1.33 1.20 1.38 1.41 ND ND
14 (6) 7.43 6.64 8.03 1.71 7.90 7.05 5.44 4.69 1:80
15 (3) 7.44 6.98 8.32 2.89 2.96 3.04 2.43 2.44 1:160
16 (13) 2.88 2.30 4.17 1.01 1.07 1.37 1.47 1.80 <1:10
17 (4) 1.20 0.85 0.90 1.07 0.94 1.34 1.34 1.49 ND
18 (8) 1.09 0.97 1.01 ND 0.67 0.77 0.75 ND ND
19 (73) 1.04 0.96 0.95 ND 0.71 0.80 0.79 ND ND
20 (8) 1.10 1.14 1.01 ND 0.72 0.82 0.82 ND ND
21 (0) 1.06 0.92 0.88 0.91 0.79 0.88 1.11 0.90 ND
Total no. positive 11 11 13 10 10 10
a

SLE virus MAC and IgG ELISAs were conducted as a separate test. Nt antibody titer was assayed in a 90% plaque reduction neutralization test against WN virus. ND, not done. 

HHS Vulnerability Disclosure